Report ID: PMRREP3144
Report Type: Ongoing
Format: PPT*, PDF, EXCEL
Industry: Healthcare
The global pharmaceutical packaging market size is expected to rise from US$130 Bn in 2024 to US$253 Bn by the end of 2031. The market is anticipated to secure a CAGR of 10% during the forecast period from 2024 to 2031.
Key Highlights of the Market
|
Attributes |
Key Insights |
|
Market Size (2024E) |
US$130 Bn |
|
Projected Market Value (2031F) |
US$253 Bn |
|
Forecast Growth Rate (CAGR 2024 to 2031) |
10% |
|
Historical Growth Rate (CAGR 2019 to 2023) |
9% |
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get Report Sample
Pharmaceutical packaging is an essential part of pharmaceuticals product and drug delivery system in the pharmaceutical industry. Pharmaceutical packaging protects products from physical damage, biological contamination and from all adverse external influences which can damage the properties of the products.
Regulation implemented by authorized agencies such as Food and Drug Administration (FDA), National Quality Forum (NQF) and Healthcare Compliance Packaging Council (HCPC) for packaging is also driving the growth of the pharmaceutical packaging market.
Nano enabled pharmaceutical packaging open new opportunities for the growth of market. Nanotechnology, biotechnology and electronics plays important role in enhancing functionality of packaging.
The US market is driving the growth of North America market for pharmaceutical packaging due to presence of health conscious people and their high spending power. The US market is expected to maintain moderate growth due to increasing aging population, robust innovations and increasing consumer demand for sophisticated packaging.
Technological innovation in packaging and integration and advanced manufacturing process are some of the driving factors responsible for the growth of pharmaceutical packaging market in the US.
Some of the recent market trends in the field of market are advancement in packaging technologies and emergence of new medicinal products. In addition, eco-friendly packaging and child resistant packaging is also gaining popularity due to special blister packs and cardboard packaging.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionRising global healthcare spending has driven demand for pharmaceutical products, consequently boosting the demand for pharmaceutical packaging.
Innovations in drug formulations and delivery methods have necessitated packaging solutions that ensure stability and efficacy, contributing to market growth. The market for pharmaceutical packaging held a CAGR of 9% during the historical period.
The global pharmaceutical market is expected to expand due to aging populations, rising chronic diseases, and increasing access to healthcare, all of which will drive demand for pharmaceutical packaging.
Growing emphasis on sustainable packaging solutions due to environmental concerns and regulatory pressures will drive innovation and adoption of eco-friendly materials in pharmaceutical packaging. The market is expected to record a CAGR of 9% during the forecast period.
Growing Demand from Pharmaceutical Industry
Growing demand from the pharmaceutical industry serves as a significant driver for the pharmaceutical packaging market, influencing its expansion in multifaceted ways.
As global healthcare expenditures continue to rise and populations age, there is a concurrent increase in the consumption of pharmaceutical products worldwide. This surge necessitates robust packaging solutions that not only ensure the safety, integrity, and efficacy of drugs but also comply with stringent regulatory standards.
Pharmaceutical companies are increasingly investing in advanced packaging technologies and materials to meet these demands, including innovations in smart packaging for enhanced traceability and patient compliance.
The advent of biologics and personalized medicine further complicates packaging requirements, driving the need for specialized packaging solutions that maintain stability and prevent contamination.
With this, the pharmaceutical packaging market is experiencing significant growth as it adapts to these evolving industry dynamics, positioning itself as a critical enabler of safe and efficient pharmaceutical delivery across global markets.
Increasing Global Healthcare Expenditure
With increasing healthcare expenditures globally, driven by factors such as rising chronic diseases, aging populations, and expanding access to medical care, there is a parallel surge in demand for pharmaceutical products.
The heightened demand necessitates packaging solutions that not only ensure the safety and efficacy of drugs but also comply with stringent regulatory standards across different regions. Pharmaceutical companies are compelled to invest in advanced packaging technologies and materials to meet these requirements effectively.
Disruptions in Supply Chain of Raw Materials
Any disruptions in the supply chain of raw materials can lead to shortages or delays in manufacturing pharmaceutical packaging. This can be caused by various factors such as natural disasters, geopolitical tensions, transportation issues, or unexpected demand spikes.
Pharmaceutical packaging materials must meet stringent quality standards and regulatory compliance requirements to ensure product safety and efficacy. Limited availability of raw materials that meet these standards can hinder the ability of packaging manufacturers to produce compliant packaging solutions.
Stringent Regulations and Standards Imposed by Health Authorities
Stringent regulations and standards imposed by health authorities across different regions can pose significant challenges for pharmaceutical packaging manufacturers. Compliance with these regulations adds complexity and costs to the development and production of packaging solutions.
Regulatory requirements for pharmaceutical packaging are stringent and complex, varying across different regions and countries. Manufacturers must ensure compliance with standards that dictate aspects such as material safety, stability testing, labeling, and child-resistant packaging.
Meeting these requirements necessitates substantial investment in testing, documentation, and regulatory approvals, which can be time-consuming and costly.
Differences in regulatory requirements across regions create a fragmented global market for pharmaceutical packaging. Companies must navigate varying standards and adapt their packaging solutions accordingly, which adds complexity to international operations and increases costs.
Increasing Boom Around Specialty Drugs and Personalized Medicine
Specialty drugs often require specialized packaging solutions to maintain stability, ensure proper administration, and enhance patient adherence. These drugs may be sensitive to environmental factors or require precise dosing mechanisms, prompting the development of innovative packaging technologies.
Personalized medicine involves tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. This customization extends to packaging, where unique packaging solutions can enhance patient engagement, provide clear instructions, and improve overall treatment outcomes.
Specialty drugs and personalized medicine often utilize advanced drug delivery systems and biotechnologies. Packaging innovations, such as smart packaging with RFID tags or temperature-sensitive labels, can integrate with these technologies to provide real-time monitoring, enhance supply chain visibility, and ensure product efficacy.
Development of Intelligent Packaging Technologies
Intelligent packaging technologies, such as Radio Frequency Identification (RFID) tags, Near Field Communication (NFC), and QR codes, enable real-time tracking and monitoring of pharmaceutical products throughout the supply chain. This capability ensures product authenticity, reduces the risk of counterfeit medicines, and enhances overall product safety and integrity.
By providing real-time information on product location, condition, and storage conditions, intelligent packaging technologies optimize supply chain management.
It includes better inventory control, reduced wastage, improved demand forecasting, and enhanced logistical efficiencies, ultimately lowering costs and improving overall operational performance.
Smart packaging can incorporate features designed to improve patient engagement and medication adherence. This includes interactive packaging with digital instructions, dosage reminders, and educational content accessible via smartphones or other devices.
Such innovations enhance patient understanding, compliance with treatment protocols, and overall health outcomes.
Adopting intelligent packaging technologies allows pharmaceutical companies and packaging manufacturers to differentiate their products in the market.
By offering enhanced safety features, supply chain visibility, and patient-centric functionalities, they can attract customers seeking advanced, reliable packaging solutions that meet modern healthcare demands.
Plastics & Polymers Continue to Capture a Significant Revenue Share
|
Category |
Market Share in 2023 |
|
Plastics & Polymers – Material Type |
34.5% |
Based on material type, plastics & polymers exhibited the large revenue share of 34.5% in 2023 and continues in the forthcoming years.
Plastics and polymers offer a wide range of properties that make them highly suitable for pharmaceutical packaging. They can be molded into various shapes and sizes, providing flexibility in design for different dosage forms.
Additionally, they offer excellent barrier properties against moisture, oxygen, and light, crucial for maintaining the stability and shelf life of pharmaceutical products.
The pharmaceutical industry's expanding global footprint and increasing demand for medicines drive the demand for reliable and cost-effective packaging solutions.
Plastics and polymers, with their proven track record in meeting pharmaceutical packaging needs, continue to capture a significant share of the market revenue.
Pharma Manufacturing to Witness Remarkable Growth
|
Category |
Market Share in 2023 |
|
Pharma Manufacturing |
48.7% |
Pharma manufacturing is estimated to record healthy growth in the foreseeable future. This end user exhibited the high share of 48.7% in 2023.
The pharmaceutical industry produces a vast array of medicines ranging from tablets and capsules to injectable, liquids, and biologics.
Each of these product types requires specific packaging solutions to ensure stability, safety, and efficacy.
The diverse range of pharmaceutical products translates into a continuous demand for packaging materials and technologies tailored to meet these varied needs.
Packaging plays a crucial role in the pharmaceutical supply chain, ensuring the safe transportation, storage, and distribution of medicines from manufacturing facilities to end-users.
Pharmaceutical manufacturers collaborate closely with packaging suppliers to optimize supply chain logistics, reduce transit risks, and maintain product integrity throughout the distribution process.
There is a growing emphasis on patient-centric packaging designs that enhance medication adherence, ease of use, and patient safety.
Pharmaceutical manufacturers invest in packaging innovations that improve patient outcomes and satisfaction, thereby strengthening brand loyalty and market competitiveness.
Asia Pacific to Demonstrate a Notable Growth Rate
|
Region |
CAGR through 2031 |
|
Asia Pacific |
11% |
Asia Pacific is witnessing significant growth in its pharmaceutical sector driven by increasing healthcare expenditures, rising population, expanding middle-class, and improving healthcare infrastructure.
The growth of this region translates into higher demand for pharmaceutical products and consequently for advanced packaging solutions to ensure product safety, integrity, and compliance with regulatory standards. This region expected to hold the notable CAGR of 11% in the forthcoming years.
There is a noticeable shift towards the production and consumption of generic drugs and biologics in Asia Pacific. These specialized pharmaceutical products often require sophisticated packaging solutions to maintain stability and enhance patient safety.
The adoption of innovative packaging technologies, such as smart packaging and tamper-evident features, is expected to support this growth.
Governments across the Asia Pacific region are implementing initiatives to enhance healthcare access and affordability.
The key initiatives include investments in pharmaceutical manufacturing capabilities, regulatory reforms to streamline approvals, and incentives to attract foreign investments in healthcare infrastructure. Such initiatives create a conducive environment for pharmaceutical packaging market growth.
Market players offer a wide range of packaging solutions in the market. In the dynamic global market, fierce competition prevails as numerous players vie for prominence worldwide. Key industry leaders are strategically solidifying their market footholds through acquisitions, heightening the competitive landscape.
A few of the leading pharmaceutical packaging companies in the market are MeadWestvaco Corporation, WestRock Company, and Alexander (James) Corporation. This intensified rivalry sees key players actively pursuing agreements with prominent pharmaceutical manufacturers, underscoring the high stakes and robust competition within the global arena.
January 2023
In January 2023, Aptar Pharma, a key pharmaceutical packaging industry, introduced a ground-breaking recyclable high-performance nasal spray. This innovation not only meets the rising demand for eco-conscious packaging solutions but also underscores Aptar Pharma's commitment to sustainable practices within the industry.
November 2023
Amcor Plc, globally recognized for pioneering eco-friendly packaging solutions, announced a strategic Memorandum of Understanding (MOU) with NOVA Chemicals Corporate. This partnership entails sourcing mechanically recycled polyethylene resin (rPE) from NOVA Chemicals Corporate to manufacture flexible packaging films.
Amcor's commitment to enhancing packaging circularity is underscored by this initiative, aiming to elevate the use of rPE in flexible packaging applications. This collaboration marks a significant step in advancing sustainable practices within the industry, aligning with both companies' shared vision of reducing environmental impact while meeting the evolving demands for innovative, eco-conscious packaging solutions.
May 2023
Bormioli Pharma, renowned for its expertise in manufacturing glass and plastic primary packaging for pharmaceutical products, unveiled its ground-breaking Eco Positive label in Many 2023. This initiative marks a significant step forward in the company's commitment to sustainability across its entire product range.
The EcoPositive label encompasses a comprehensive array of offerings, including recycled glass and plastics, bio-based materials, compostable solutions, and cutting-edge polymer products. This bold move underscores.
|
Attributes |
Details |
|
Forecast Period |
2024 to 2031 |
|
Historical Data Available for |
2019 to 2023 |
|
Market Analysis |
US$ Billion for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon request |
By Type
By Drug Delivery
By Packaging Type
By Raw Material
By End-Use Industry
By Region
For report customisation and delivery information contact our sales representative.
Increasing healthcare expenditures globally is a key factor driving market growth.
A few of the leading industry players in the market are Baxter International Incorporated, Amcor Limited, and Centor and Lilly (Eli) Company.
Development of intelligent packaging technologies is a key opportunity in the market.
Asia pacific to hold the notable growth rate in the market.
Plastics & polymers to capture notable share in the market.
